Results 231 to 240 of about 8,942,088 (298)

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Federal and Industry Sponsorship in US Cancer Clinical Trials.

JAMA Oncol
Unger JM, Xiao H, LeBlanc ML, Hershman DL.   +3 more
europepmc   +1 more source

Variation in Clinical Teaching Fellow Programmes: Problem or Insight? [PDF]

Clin Teach
Jones N, Khan Z, Hofmann R.
europepmc   +1 more source

Response to van Boxtel <i>et al.</i>, 'Testing errors in measuring the effective orifice diameter as a new sizing parameter of surgical valve prostheses'. [PDF]

Ann Cardiothorac Surg
Wu C, Green C, Marquez S, Monelli P, Weinberg C, Weston M, Cameron D, Yoganathan A, Steinseifer U.   +8 more
europepmc   +1 more source

Put purpose before process: lessons from evaluating patient involvement in governance structures in health research organisations. [PDF]

Res Involv Engagem
Staley K.
europepmc   +1 more source

Metacognition in AI-Supported Second Language Learning: A Systematic Review of Constructs, Measures, and Evidence (2016-2026). [PDF]

J Intell
Yi H, Chen Q, Wang Z.
europepmc   +1 more source